CPT1A loss disrupts BCAA metabolism to confer therapeutic vulnerability in TP53-mutated liver cancer.

Cancer letters2024Liu Y, Wang F, Yan G, et al.

Study designOther primary literature

SubjectHuman & animal

Record checks

Study design: Other primary literature
Subject: Human & animal
Publication year: 2024
Source: doi.org
Abstract display: Not reproduced here
Publication status: Active
Status checked: 17 Aug 2026
Collected: 3 Aug 2026
Freshness: Current
Review stage: Automated
Record status: Published

How to read this record →

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

Acetyl Coenzyme AAmino Acids, Branched-ChainAnimalsCarcinoma, HepatocellularCarnitine O-PalmitoyltransferaseCell Line, TumorGene Expression Regulation, NeoplasticHumansLipid MetabolismLiver NeoplasmsMaleMiceMutationSignal TransductionTOR Serine-Threonine KinasesTumor Suppressor Protein p53Xenograft Model Antitumor Assays

DOI 10.1016/j.canlet.2024.217006

PMID 38823763

View source →